Published in J Neurol on August 01, 2004
Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol (2010) 1.70
Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption. Sleep Med (2011) 0.85
Pain and motor function in carpal tunnel syndrome: a clinical, neurophysiological and psychophysical study. J Neurol (2008) 0.85
Restless legs syndrome: differential diagnosis and management with pramipexole. Clin Interv Aging (2009) 0.78
Quantitative thermal sensory testing and sympathetic skin response in primary Restless legs syndrome - A prospective study on 57 Indian patients. Ann Indian Acad Neurol (2012) 0.77
Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials. Neuropsychiatr Dis Treat (2013) 0.76
Pramipexole alters thermoregulation in restless legs syndrome. J Clin Sleep Med (2014) 0.75
Restless Legs Syndrome: Current Concepts about Disease Pathophysiology. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
The higher prevalence of non-right handers among patients with restless leg syndrome. Neurol Sci (2014) 0.75
Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry (1976) 4.13
Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord (1995) 3.34
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Ropinirole for restless legs syndrome. Mov Disord (1999) 1.54
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology (1999) 1.46
Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology (2000) 1.45
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain (2001) 1.37
Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. Brain (1992) 1.34
Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol (1997) 1.23
Restless legs syndrome: clinicoetiologic correlates. Neurology (1996) 1.07
Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord (1995) 1.02
Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve (1993) 0.99
Restless legs syndrome in patients with polyneuropathy. Muscle Nerve (1996) 0.93
Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology (1998) 0.91
Motor system excitability in patients with restless legs syndrome. Neurology (1999) 0.88
Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J Neurol (2000) 0.87
Reflex studies and MRI in the restless legs syndrome. Acta Neurol Scand (1996) 0.86
Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain (1993) 0.83
Small nerve fiber dysfunction in diabetic neuropathy. Muscle Nerve (1989) 0.82
Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry (1990) 0.78
Nerve conduction and creatinine clearance in aged subjects with periodic movements in sleep. J Gerontol (1989) 0.77
Utility of the skin biopsy method in studies of diabetic neuropathy. Electroencephalogr Clin Neurophysiol Suppl (1999) 0.77
[Restless legs syndrome and periodic limb movements in sleep]. Nervenarzt (2001) 0.77
Evaluation of thermal and pain sensitivity in type I diabetic patients. J Neurol Neurosurg Psychiatry (1991) 0.77
Somatosensory and brainstem auditory evoked responses in sleep-related periodic leg movements. Sleep (1986) 0.76
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin (2006) 4.78
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain (2007) 3.91
A new definition of neuropathic pain. Pain (2011) 3.57
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol (2010) 3.31
The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke (2011) 3.03
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
Interventional management of neuropathic pain: NeuPSIG recommendations. Pain (2013) 2.75
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord (2006) 2.53
The Pharmacological Therapy of Chronic Neuropathic Pain. Dtsch Arztebl Int (2016) 2.45
Is CRPS I a neuropathic pain syndrome? Pain (2006) 2.40
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int (2010) 2.27
Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med (2006) 2.26
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol (2010) 1.98
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol (2012) 1.93
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Red flags for multiple system atrophy. Mov Disord (2008) 1.75
Complex regional pain syndrome: mystery explained? Lancet Neurol (2003) 1.75
Continuous theta-burst stimulation of the primary motor cortex in essential tremor. Clin Neurophysiol (2011) 1.73
Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord (2011) 1.70
Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain (2011) 1.70
Cortical correlates of the basic and first harmonic frequency of Parkinsonian tremor. Clin Neurophysiol (2009) 1.65
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord (2014) 1.63
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol (2008) 1.62
Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr (2010) 1.61
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord (2003) 1.58
Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain (2004) 1.58
Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord (2010) 1.55
Falls in frequent neurological diseases--prevalence, risk factors and aetiology. J Neurol (2004) 1.48
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. Pain (2015) 1.47
Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain (2006) 1.45
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting. Pain (2015) 1.44
Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injury. Pain (2012) 1.43
Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J (2003) 1.43
Complex regional pain syndrome-a multifaceted disorder requiring multidimensional care: case study. J Pain (2007) 1.42
Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology (2012) 1.41
The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep (2009) 1.40
Do we need a third mechanistic descriptor for chronic pain states? Pain (2016) 1.39
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol (2012) 1.37
Translation of symptoms and signs into mechanisms in neuropathic pain. Pain (2003) 1.36
The motor system shows adaptive changes in complex regional pain syndrome. Brain (2007) 1.36
Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain (2010) 1.36
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin (2006) 1.34
Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord (2002) 1.34
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci (2010) 1.30
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging (2008) 1.28
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain (2003) 1.28
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
How to assess motor impairment in writer's cramp. Mov Disord (2007) 1.24
Sensory symptom profiles and co-morbidities in painful radiculopathy. PLoS One (2011) 1.23
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin (2009) 1.23
Cortical involvement in the generation of essential tremor. J Neurophysiol (2007) 1.23
Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch Neurol (2004) 1.23
Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease. Mov Disord (2004) 1.22
Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor. Brain (2007) 1.22
Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord (2003) 1.20
The pathophysiology of essential tremor and Parkinson's tremor. Curr Neurol Neurosci Rep (2013) 1.20
Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Stroke (2004) 1.19
Quality of life and personality in essential tremor patients. Mov Disord (2006) 1.19
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord (2010) 1.18
Update on pathogenesis and treatment of essential tremor. Curr Opin Neurol (2007) 1.17
A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) (2010) 1.17
Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother (2007) 1.16
Harlequin syndrome--one face of many etiologies. Nat Clin Pract Neurol (2005) 1.15
Receptor kinase signaling pathways in plant-microbe interactions. Annu Rev Phytopathol (2012) 1.15
An update on tremors. Curr Opin Neurol (2012) 1.15
Assessment of neuropathic pain in primary care. Am J Med (2009) 1.14
FRET-based genetically encoded sensors allow high-resolution live cell imaging of Ca²⁺ dynamics. Plant J (2011) 1.13
Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain (2009) 1.12
Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res (2002) 1.12
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11